Cover Image
市場調查報告書

醫療分析學:技術及全球市場

Healthcare Analytics: Technologies and Global Markets

出版商 BCC Research 商品編碼 345376
出版日期 內容資訊 英文 119 Pages
訂單完成後即時交付
價格
Back to Top
醫療分析學:技術及全球市場 Healthcare Analytics: Technologies and Global Markets
出版日期: 2015年11月19日 內容資訊: 英文 119 Pages
簡介

全球醫療分析學市場2014年為48億美金。該市場今後預計2020年以年複合成長率24%擴大,從2015年的58億美元到2020年的169億美元。

本報告提供全球醫療分析學市場概要與到2020年的預測,市場成長的促進要素與阻礙要素分析,各種產業進入者簡介彙整。

第1章 簡介

第2章 摘要

第3章 市場情況

  • 簡介
  • 醫療產業
  • 定義
  • 分析學的種類
  • 市場區隔
  • 醫療的巨量資料
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 問題
    • 吃緊的課題
    • 醫療分析學傳輸模式
    • 重要成功因素

第4章 各用途市場

  • 簡介
  • 臨床分析學
  • 實際業務管理分析學
  • 其他
  • 各終端用戶市場

第5章 各傳輸模式市場

  • 簡介
  • 內部部署
  • 網站託管
  • 雲端基礎

第6章 各產品市場

  • 簡介
  • 硬體設備
  • 軟體
  • 服務

第7章 企業簡介

  • CERNER CORP.
  • FUZZY LOGIX LLC
  • HUMEDICA INC.
  • INFORMATION BUILDERS
  • KYRUUS
  • LEXISNEXIS
  • MCKESSON CORP.
  • MEDEANALYTICS INC.
  • OPTUM
  • ORACLE CORP.
  • PREDIXION SOFTWARE ?RECENT DEVELOPMENTS
  • REVSPRING
  • SAS INSTITUTE INC.
  • TRUVEN HEALTH ANALYTICS INC.
  • VERISK ANALYTICS
  • 其他

第8章 簡稱清單

第9章 補充表

圖表

目錄
Product Code: HLC187A

REPORT HIGHLIGHTS

The global market for healthcare analytics reached $4.8 billion in 2014. This market is forecasted to grow at a compound annual growth rate (CAGR) of 24.0% to reach nearly $16.9 billion in 2020 from nearly $5.8 billion in 2015.

This report provides:

  • An overview of the global markets for healthcare analytics.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
  • A look at how healthcare analytics utilizes systematic data from clinical and business fronts to arrive at insights which are developed with the help of statistical, contextual, quantitative, predictive, and cognitive spectrums.
  • Evaluation of factors driving the market such as the introduction of federal healthcare policies, increased focus on data collection and analysis for better customer service, progress in clinical outcomes, rapid technological advances and the emergence of social media.
  • Analysis of growth inhibitors such as data security issues, patient data confidentiality, cultural barriers to IT adoption, and lack of manpower with cross-functional analytical skills.
  • A look at the role different participants in the industry play including the government, insurers, medical staff, physicians and others.

SCOPE OF REPORT

This research report categorizes the market for healthcare analytics into three types of applications: clinical analytics, business analytics and other analytics.

Clinical analytics is segmented as follows:

  • Performance measurement.
  • Regulatory reporting.
  • Compliance and transparency.
  • Provider performance.
  • Quality improvement.
  • Clinical benchmarking.
  • Clinical decision support (CDS).
  • Population health management.
  • Public health surveillance.

Business analytics is segmented as follows:

  • Financial analytics
    • Claim analytics.
    • Revenue management.
    • Risk management analytics.
  • Operational analytics.
    • Supply chain management.
    • Human resources.
    • Strategic analytics.

“Other” analytics include:

  • Tools used for research results analysis.
  • Other analytics function.

The market for healthcare analytics is segmented by end user as follows:

  • Payers.
    • Government.
    • Private.
  • Providers.
    • Hospitals.
    • Medical groups.
    • Physician practices.
    • Others.

The following geographic markets are analyzed:

  • United States.
  • Europe.
  • Asia.
  • Rest of the world (ROW).

The analysis includes the following types of delivery modes:

  • On-premises.
  • Web-hosted.
  • Cloud-based.

Lastly, the market is analyzed by product and segmented as follows:

  • Hardware.
  • Software.
  • Services.

ANALYST'S CREDENTIALS

Neha Maliwal, a graduate in biotechnology and a postgraduate in marketing and biotechnology at the University of Pune(India), is the author of this study and numerous others, including the analyses of related markets such as antibiotics, radiopharmaceuticals, radiotherapy, healthcare business process outsourcing (BPO) and biotechnology instrumentation.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • RESEARCH METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY MAJOR SEGMENT, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY MAJOR SEGMENT, 2014-2020 ($ MILLIONS)

CHAPTER 3 - MARKET OVERVIEW

  • INTRODUCTION
  • HEALTHCARE INDUSTRY
    • FIGURE 1: MAIN PARTICIPANTS OF THE HEALTHCARE INDUSTRY
  • DEFINITION
  • TYPES OF ANALYTICS
    • DESCRIPTIVE ANALYTICS
    • PREDICTIVE ANALYTICS
      • TABLE 1: APPLICATION OF PREDICTIVE ANALYTICS
      • Fraud Detection
    • PRESCRIPTIVE ANALYTICS
  • HEALTHCARE ANALYTICS SEGMENTATION
    • FIGURE 2: MARKET FOR HEALTHCARE ANALYTICS
  • BIG DATA IN HEALTHCARE
    • TABLE 2: 5 V'S OF BIG DATA IN HEALTHCARE
    • TABLE 3: TRENDS AND CHALLENGES IMPACTING BIG DATA IN HEALTHCARE
    • TABLE 4: HEALTHCARE ANALYTICS WORKFLOW
  • MARKET DYNAMICS
    • FIGURE 3: MARKET DYNAMICS OF HEALTHCARE ANALYTICS
    • DRIVERS
      • Improved Clinical Outcomes
      • U.S. Government Initiatives
      • Hardware Advancements
        • TABLE 5: IMPACT OF TECHNOLOGY ON ANALYTICS
      • Margin Pressures Increasing Use of Analytics
      • Payer-Provider Convergence
      • Rising Healthcare Cost
    • RESTRAINTS
      • Lack of Uniformity in Healthcare Data
      • Resistance to IT-Based Approach by Medical Professionals
      • Operational Gap between Payer and Provider
    • OPPORTUNITIES
      • EHR's Increasing Data Volumes
      • Rising Importance of Value-Based Medicine Due to Peer Pressure
      • Health Information Exchange
      • Easy to Handle Big Data
      • Emergency Care and Preventive Care
      • Saves Time and Cost
      • Data Clarity and Transparency
      • Fraud Detection
    • CHALLENGES
      • Financial Constraints
      • Ensuring Patient Confidentiality
      • Traditional Techniques
    • BURNING ISSUES
      • Rising Demand of Healthcare Analytics Professionals
      • Interoperability a Focus Area
      • Providers Will Drive the Market for Analytics
        • TABLE 6: MARKET CATALYST, IMPACT AND HEALTHCARE IT SOLUTIONS
    • HEALTHCARE ANALYTICS DELIVERY MODELS
      • TABLE 7: DEPLOYMENT MODELS FOR ANALYTICS
    • KEY SUCCESS FACTORS
      • FIGURE 4: KEY SUCCESS FACTORS IN HEALTHCARE ANALYTICS
      • Inclusive Leaders
      • Communication and Learning
      • Embedded Analytics
      • Transparency
      • Real-Time Monitoring
      • Incorporation of Staff Feedback

CHAPTER 4 - MARKET BY APPLICATION

  • INTRODUCTION
    • TABLE 8: HEALTHCARE ANALYTICS APPLICATION-BASED DATA
  • CLINICAL ANALYTICS
    • MARKET DYNAMICS
      • Driver
        • EHR Effectiveness Boosted by Clinical Analytics
        • Increase in the Amount of Clinical Data
        • Cost-Effective Treatment is Provided
      • Restraint
        • No Standardized Data Format
    • MARKET BY APPLICATION SEGMENT
      • TABLE 9: GLOBAL MARKET FOR CLINICAL HEALTHCARE ANALYTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
      • TABLE 10: GLOBAL MARKET FOR CLINICAL HEALTHCARE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Performance Measurement
        • TABLE 11: GLOBAL MARKET FOR PERFORMANCE MEASUREMENT SYSTEMS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Regulatory Reporting, Compliance and Transparency
        • TABLE 12: GLOBAL MARKET FOR REGULATORY REPORTING AND COMPLIANCE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Provider Performance
        • TABLE 13: GLOBAL MARKET FOR PROVIDER PERFORMANCE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Quality Improvement
        • TABLE 14: GLOBAL MARKET FOR QUALITY IMPROVEMENT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Clinical Benchmarking
        • TABLE 15: GLOBAL MARKET FOR CLINICAL BENCHMARKING ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Clinical Decision Support
        • Examples
          • TABLE 16: GLOBAL MARKET FOR CLINICAL DECISION SUPPORT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Population Health Management
        • Comparative Effectiveness
          • TABLE 17: GLOBAL MARKET FOR POPULATION HEALTH MANAGEMENT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
        • Public Health Surveillance
          • TABLE 18: GLOBAL MARKET FOR PUBLIC HEALTH SURVEILLANCE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • BUSINESS ANALYTICS
      • TABLE 19: GLOBAL MARKET FOR BUSINESS ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • TABLE 20: GLOBAL MARKET FOR BUSINESS ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • FINANCIAL ANALYTICS
      • TABLE 21: GLOBAL MARKET FOR FINANCIAL ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • TABLE 22: GLOBAL MARKET FOR FINANCIAL ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Claim Analytics
        • Healthcare Claim Data
        • Denial Management
        • Reconciliation of Claims
        • Coordination-of-Benefit Claims
          • TABLE 23: GLOBAL MARKET FOR CLAIMS ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
        • Revenue Management
          • TABLE 24: GLOBAL MARKET FOR REVENUE MANAGEMENT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
        • Risk Management Analytics
        • TABLE 25: GLOBAL MARKET FOR RISK MANAGEMENT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
  • OPERATIONAL AND ADMINISTRATIVE ANALYTICS
    • TABLE 26: GLOBAL MARKET FOR OPERATIONAL AND ADMINISTRATIVE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: GLOBAL MARKET FOR OPERATIONAL AND ADMINISTRATIVE HEALTHCARE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • Supply Chain Management
      • TABLE 28: GLOBAL MARKET FOR SUPPLY CHAIN ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • Human Resources
      • TABLE 29: GLOBAL MARKET FOR HUMAN RESOURCE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • Strategic Analytics
      • TABLE 30: GLOBAL MARKET FOR STRATEGIC ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
  • OTHERS
    • TABLE 31: GLOBAL MARKET FOR OTHER ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
  • GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY END USER
    • INTRODUCTION
      • TABLE 32: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS BY END USER, THROUGH 2020 ($ MILLIONS)
      • TABLE 33: GLOBAL MARKET FOR END USER HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • PAYERS
      • Clinical and Financial Data Integration
      • Clinical Data Challenge for Payers
        • Incompatible Systems
        • Siloed, Manual, Incongruent Aggregation of Clinical Data
        • Clinical Data Quality and Terminology Gaps
        • Overcoming Integration Challenges
          • TABLE 34: INTEGRATION PHASE
        • Building a Mechanism for Seamless Sharing of Clinical Data
        • Going from Clinical Data Convergence to Actionable Insights
        • Defining the Right Use Cases.
          • TABLE 35: USE CASE, NEED FOR DATA INTEGRATION AND IMPACT
        • Making the Aggregated Data Meaningful to Payer Operations.
          • TABLE 36: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY PAYERS BY TYPE, THROUGH 2020 ($ MILLIONS)
          • TABLE 37: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY PAYERS BY REGION, THROUGH 2020 ($ MILLIONS)
        • Government-Sponsored Insurance Programs
          • TABLE 38: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS IN GOVERNMENT-SPONSORED INSURANCE PROGRAMS BY REGION, THROUGH 2020 ($ MILLIONS)
        • Private Insurers
    • PROVIDERS
      • TABLE 39: CLAIMS AND EMR DATA
      • TABLE 40: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY PROVIDERS BY TYPE, THROUGH 2020 ($ MILLIONS)
      • TABLE 41: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY PROVIDERS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Hospitals
        • TABLE 42: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY HOSPITALS BY REGION, THROUGH 2020 ($ MILLIONS)
      • Medical Groups and Physician Practices
        • TABLE 43: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY MEDICAL GROUPS AND PHYSICIAN PRACTICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • OTHERS
      • TABLE 44: GLOBAL MARKET FOR OTHER HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
  • GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY REGION
    • INTRODUCTION
      • TABLE 45: GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • UNITED STATES
      • TABLE 46: U.S. MARKET FOR HEALTHCARE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • EUROPE
      • TABLE 47: EUROPEAN MARKET FOR HEALTHCARE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • ASIA-PACIFIC
      • TABLE 48: ASIA-PACIFIC MARKET FOR HEALTHCARE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • REST OF THE WORLD
      • TABLE 49: REST OF THE WORLD MARKET FOR HEALTHCARE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)

CHAPTER 5 - GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY DELIVERY MODE

  • INTRODUCTION
    • TABLE 50: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS BY DELIVERY MODE, THROUGH 2020 ($ MILLIONS)
  • ON-PREMISES
    • TABLE 51: GLOBAL MARKET FOR ON-PREMISE HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
  • WEB-HOSTED
    • TABLE 52: GLOBAL MARKET FOR WEB-HOSTED HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
  • CLOUD-BASED
    • TABLE 53: GLOBAL MARKET FOR CLOUD-BASED HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 6 - GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY PRODUCT: HARDWARE, SOFTWARE AND SERVICES

  • INTRODUCTION
    • TABLE 54: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
  • HARDWARE
    • TABLE 55: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS HARDWARE BY REGION, THROUGH 2020 ($ MILLIONS)
    • ACCESS DEVICES
    • PERIPHERALS
    • SERVERS
    • STORAGE DEVICES
    • NETWORKING DEVICES
  • SOFTWARE
    • TABLE 56: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS SOFTWARE BY REGION, THROUGH 2020 ($ MILLIONS)
  • SERVICES
    • TABLE 57: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS SERVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • CONSULTING
    • IMPLEMENTATION SERVICES AND ONGOING IT SUPPORT
    • TRAINING AND EDUCATION
    • POST-SALE AND MAINTENANCE

CHAPTER 7 - COMPANY PROFILES

  • CERNER CORP.
    • FINANCIALS
      • TABLE 58: CERNER CORP. REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
      • TABLE 59: CERNER CORP. REVENUES BY SEGMENT, 2012-2014 ($ MILLIONS)
      • TABLE 60: CERNER CORP. REVENUES BY REGION, 2012-2014 ($ MILLIONS)
  • PRODUCTS
    • RECENT DEVELOPMENTS
      • TABLE 61: RECENT DEVELOPMENTS AT CERNER
  • FUZZY LOGIX LLC
  • HUMEDICA INC.
    • FINANCIALS
      • TABLE 62: UNITED HEALTH GROUP REVENUES, 2012-2014 ($ MILLIONS)
  • IBM CORP.
    • FINANCIALS
      • TABLE 63: IBM REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • RECENT DEVELOPMENTS
      • TABLE 64: RECENT DEVELOPMENTS AT IBM
  • INFORMATION BUILDERS
    • RECENT DEVELOPMENTS
      • TABLE 65: RECENT DEVELOPMENTS AT INFORMATION BUILDERS
  • INOVALON
    • FINANCIALS
      • TABLE 66: INOVALON REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • RECENT DEVELOPMENTS
      • TABLE 67: RECENT DEVELOPMENTS AT INOVALON
  • KYRUUS
    • RECENT DEVELOPMENTS
      • TABLE 68: RECENT DEVELOPMENTS AT KYRUUS
  • LEXISNEXIS
    • TABLE 69: REED ELSEVIER REVENUES, 2012-2014 ($ MILLIONS)
    • TABLE 70: REED ELSEVIER REVENUES BY SEGMENT, 2012-2014 ($ MILLIONS)
    • DEVELOPMENTS
      • TABLE 71: RECENT DEVELOPMENTS AT REED ELSEVIER
  • MCKESSON CORP.
    • FINANCIALS
      • TABLE 72: MCKESSON REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
      • TABLE 73: MCKESSON REVENUES BREAKDOWN BY SEGMENT, 2012-2014 ($ MILLIONS)
    • PRODUCTS
      • TABLE 74: MCKESSON PRODUCTS
    • RECENT DEVELOPMENTS
      • TABLE 75: RECENT DEVELOPMENTS AT MCKESSON
  • MEDEANALYTICS INC.
    • RECENT DEVELOPMENTS
      • TABLE 76: RECENT DEVELOPMENTS AT MEDEANALYTICS
  • MICROSTRATEGY
    • FINANCIALS
      • TABLE 77: MICROSTRATEGY REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • RECENT DEVELOPMENTS
      • TABLE 78: RECENT DEVELOPMENTS AT MICROSTRATEGY
  • OPTUM
    • DEVELOPMENTS
      • TABLE 79: DEVELOPMENTS AT OPTUM
  • ORACLE CORP.
    • FINANCIALS
      • TABLE 80: ORACLE REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • RECENT DEVELOPMENTS
      • TABLE 81: RECENT DEVELOPMENTS AT ORACLE
  • PREDIXION SOFTWARE
    • RECENT DEVELOPMENTS
      • TABLE 82: RECENT DEVELOPMENTS AT PREDIXION SOFTWARE
  • REVSPRING
    • RECENT DEVELOPMENTS
      • TABLE 83: RECENT DEVELOPMENTS AT REVSPRING
  • SAS INSTITUTE INC.
    • FINANCIALS
      • TABLE 84: SAS REVENUES BY REGION, 2012-2014 ($ MILLIONS)
      • TABLE 85: SAS REVENUES BY INDUSTRY, 2012-2014 ($ MILLIONS)
    • RECENT DEVELOPMENTS
      • TABLE 86: RECENT DEVELOPMENTS AT SAS
  • TRUVEN HEALTH ANALYTICS INC.
    • RECENT DEVELOPMENTS
      • TABLE 87: RECENT DEVELOPMENTS AT TRUVEN HEALTH
  • VERISK ANALYTICS
    • FINANCIALS
      • TABLE 88: VERISK REVENUES BY SEGMENT, 2012-2014 ($ MILLIONS)
  • PRODUCTS
    • DEVELOPMENTS
      • TABLE 89: RECENT DEVELOPMENTS AT VERISK
  • OTHERS
    • METRIC INSIGHTS INC.
    • PARADIGM4
    • RAPID INSIGHT INC.
    • VANTAGE POINT HEALTHCARE INFORMATION SYSTEMS INC.

CHAPTER 8 - LIST OF ACRONYMS

CHAPTER 9 - SUPPLEMENTAL TABLES

  • TABLE 90: OPTIMIZATION SOFTWARE PRIOR TRANSACTIONS
  • TABLE 91: INFORMATICS PRIOR TRANSACTIONS
  • TABLE 92: PATIENT ENGAGEMENT AND COMMUNICATION PRIOR TRANSACTIONS
  • TABLE 93: INSURANCE TECHNOLOGY PRIOR TRANSACTIONS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY MAJOR SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: APPLICATION OF PREDICTIVE ANALYTICS
    • TABLE 2: 5 V'S OF BIG DATA IN HEALTHCARE
    • TABLE 3: TRENDS AND CHALLENGES IMPACTING BIG DATA IN HEALTHCARE
    • TABLE 4: HEALTHCARE ANALYTICS WORKFLOW
    • TABLE 5: IMPACT OF TECHNOLOGY ON ANALYTICS
    • TABLE 6: MARKET CATALYST, IMPACT AND HEALTHCARE IT SOLUTIONS
    • TABLE 7: DEPLOYMENT MODELS FOR ANALYTICS
    • TABLE 8: HEALTHCARE ANALYTICS APPLICATION-BASED DATA
    • TABLE 9: GLOBAL MARKET FOR CLINICAL HEALTHCARE ANALYTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 10: GLOBAL MARKET FOR CLINICAL HEALTHCARE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: GLOBAL MARKET FOR PERFORMANCE MEASUREMENT SYSTEMS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 12: GLOBAL MARKET FOR REGULATORY REPORTING AND COMPLIANCE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 13: GLOBAL MARKET FOR PROVIDER PERFORMANCE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET FOR QUALITY IMPROVEMENT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR CLINICAL BENCHMARKING ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: GLOBAL MARKET FOR CLINICAL DECISION SUPPORT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: GLOBAL MARKET FOR POPULATION HEALTH MANAGEMENT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 18: GLOBAL MARKET FOR PUBLIC HEALTH SURVEILLANCE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 19: GLOBAL MARKET FOR BUSINESS ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: GLOBAL MARKET FOR BUSINESS ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 21: GLOBAL MARKET FOR FINANCIAL ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: GLOBAL MARKET FOR FINANCIAL ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET FOR CLAIMS ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET FOR REVENUE MANAGEMENT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: GLOBAL MARKET FOR RISK MANAGEMENT ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 26: GLOBAL MARKET FOR OPERATIONAL AND ADMINISTRATIVE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: GLOBAL MARKET FOR OPERATIONAL AND ADMINISTRATIVE HEALTHCARE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 28: GLOBAL MARKET FOR SUPPLY CHAIN ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: GLOBAL MARKET FOR HUMAN RESOURCE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 30: GLOBAL MARKET FOR STRATEGIC ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 31: GLOBAL MARKET FOR OTHER ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 32: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS BY END USER, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: GLOBAL MARKET FOR END USER HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 34: INTEGRATION PHASE
    • TABLE 35: USE CASE, NEED FOR DATA INTEGRATION AND IMPACT
    • TABLE 36: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY PAYERS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY PAYERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS IN GOVERNMENT-SPONSORED INSURANCE PROGRAMS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: CLAIMS AND EMR DATA
    • TABLE 40: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY PROVIDERS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY PROVIDERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY HOSPITALS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 43: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS USED BY MEDICAL GROUPS AND PHYSICIAN PRACTICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 44: GLOBAL MARKET FOR OTHER HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 45: GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 46: U.S. MARKET FOR HEALTHCARE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 47: EUROPEAN MARKET FOR HEALTHCARE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 48: ASIA-PACIFIC MARKET FOR HEALTHCARE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: REST OF THE WORLD MARKET FOR HEALTHCARE ANALYTICS BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 50: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS BY DELIVERY MODE, THROUGH 2020 ($ MILLIONS)
    • TABLE 51: GLOBAL MARKET FOR ON-PREMISE HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 52: GLOBAL MARKET FOR WEB-HOSTED HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 53: GLOBAL MARKET FOR CLOUD-BASED HEALTHCARE DATA ANALYTICS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 54: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 55: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS HARDWARE BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 56: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS SOFTWARE BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 57: GLOBAL MARKET FOR HEALTHCARE DATA ANALYTICS SERVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 58: CERNER CORP. REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • TABLE 59: CERNER CORP. REVENUES BY SEGMENT, 2012-2014 ($ MILLIONS)
    • TABLE 60: CERNER CORP. REVENUES BY REGION, 2012-2014 ($ MILLIONS)
    • TABLE 61: RECENT DEVELOPMENTS AT CERNER
    • TABLE 62: UNITED HEALTH GROUP REVENUES, 2012-2014 ($ MILLIONS)
    • TABLE 63: IBM REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • TABLE 64: RECENT DEVELOPMENTS AT IBM
    • TABLE 65: RECENT DEVELOPMENTS AT INFORMATION BUILDERS
    • TABLE 66: INOVALON REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • TABLE 67: RECENT DEVELOPMENTS AT INOVALON
    • TABLE 68: RECENT DEVELOPMENTS AT KYRUUS
    • TABLE 69: REED ELSEVIER REVENUES, 2012-2014 ($ MILLIONS)
    • TABLE 70: REED ELSEVIER REVENUES BY SEGMENT, 2012-2014 ($ MILLIONS)
    • TABLE 71: RECENT DEVELOPMENTS AT REED ELSEVIER
    • TABLE 72: MCKESSON REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • TABLE 73: MCKESSON REVENUES BREAKDOWN BY SEGMENT, 2012-2014 ($ MILLIONS)
    • TABLE 74: MCKESSON PRODUCTS
    • TABLE 75: RECENT DEVELOPMENTS AT MCKESSON
    • TABLE 76: RECENT DEVELOPMENTS AT MEDEANALYTICS
    • TABLE 77: MICROSTRATEGY REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • TABLE 78: RECENT DEVELOPMENTS AT MICROSTRATEGY
    • TABLE 79: DEVELOPMENTS AT OPTUM
    • TABLE 80: ORACLE REVENUES AND R &D EXPENDITURES, 2012-2014 ($ MILLIONS)
    • TABLE 81: RECENT DEVELOPMENTS AT ORACLE
    • TABLE 82: RECENT DEVELOPMENTS AT PREDIXION SOFTWARE
    • TABLE 83: RECENT DEVELOPMENTS AT REVSPRING
    • TABLE 84: SAS REVENUES BY REGION, 2012-2014 ($ MILLIONS)
    • TABLE 85: SAS REVENUES BY INDUSTRY, 2012-2014 ($ MILLIONS)
    • TABLE 86: RECENT DEVELOPMENTS AT SAS
    • TABLE 87: RECENT DEVELOPMENTS AT TRUVEN HEALTH
    • TABLE 88: VERISK REVENUES BY SEGMENT, 2012-2014 ($ MILLIONS)
    • TABLE 89: RECENT DEVELOPMENTS AT VERISK
    • TABLE 90: OPTIMIZATION SOFTWARE PRIOR TRANSACTIONS
    • TABLE 91: INFORMATICS PRIOR TRANSACTIONS
    • TABLE 92: PATIENT ENGAGEMENT AND COMMUNICATION PRIOR TRANSACTIONS
    • TABLE 93: INSURANCE TECHNOLOGY PRIOR TRANSACTIONS

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR HEALTHCARE ANALYTICS BY MAJOR SEGMENT, 2014-2020 ($ MILLIONS)
    • FIGURE 1: MAIN PARTICIPANTS OF THE HEALTHCARE INDUSTRY
    • FIGURE 2: MARKET FOR HEALTHCARE ANALYTICS
    • FIGURE 3: MARKET DYNAMICS OF HEALTHCARE ANALYTICS
    • FIGURE 4: KEY SUCCESS FACTORS IN HEALTHCARE ANALYTICS
Back to Top